JP2012526726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526726A5 JP2012526726A5 JP2011548484A JP2011548484A JP2012526726A5 JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5 JP 2011548484 A JP2011548484 A JP 2011548484A JP 2011548484 A JP2011548484 A JP 2011548484A JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- therapeutic agent
- pharmaceutical formulation
- present
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 117
- 239000003814 drug Substances 0.000 claims description 107
- 229940124597 therapeutic agent Drugs 0.000 claims description 107
- 239000000203 mixture Substances 0.000 claims description 61
- 150000003839 salts Chemical group 0.000 claims description 57
- 241000288906 Primates Species 0.000 claims description 41
- 239000012458 free base Substances 0.000 claims description 26
- 239000001913 cellulose Substances 0.000 claims description 21
- 229920002678 cellulose Polymers 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 15
- 229920001282 polysaccharide Polymers 0.000 claims description 15
- 239000005017 polysaccharide Substances 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 13
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000856 Amylose Polymers 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000000227 bioadhesive Substances 0.000 claims description 2
- 235000019658 bitter taste Nutrition 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 150000004677 hydrates Chemical class 0.000 claims description 2
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 13
- 230000001225 therapeutic effect Effects 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17890009P | 2009-05-15 | 2009-05-15 | |
| US61/178,900 | 2009-05-15 | ||
| PCT/JP2010/003285 WO2010131486A1 (en) | 2009-05-15 | 2010-05-14 | Intranasal pharmaceutical compositions with improved pharmacokinetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012526726A JP2012526726A (ja) | 2012-11-01 |
| JP2012526726A5 true JP2012526726A5 (enExample) | 2013-06-27 |
Family
ID=43084869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548484A Pending JP2012526726A (ja) | 2009-05-15 | 2010-05-14 | 薬物動態が改善された鼻腔内用薬学的組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9101539B2 (enExample) |
| EP (1) | EP2429495A4 (enExample) |
| JP (1) | JP2012526726A (enExample) |
| WO (1) | WO2010131486A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9701737B2 (en) | 2003-02-19 | 2017-07-11 | Camas, Incorporated | Immunogen adherence and method of making and using same |
| US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
| MXPA05010379A (es) | 2003-03-27 | 2006-05-31 | Bioactis Ltd | Aparato para administrar una medicina en polvo en la cavidad intranasal. |
| US8673360B2 (en) | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
| GB0503738D0 (en) * | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
| EP3272379A1 (en) | 2008-02-07 | 2018-01-24 | The University of Washington | Circumferential aerosol device |
| GB2472327B (en) * | 2009-07-31 | 2013-03-13 | Shin Nippon Biomedical Lab Ltd | Intranasal granisetron and nasal applicator |
| US9687536B2 (en) | 2010-04-15 | 2017-06-27 | Shin Nippon Biomedical Laboratories, Ltd. | Methods and compositions for intranasal delivery |
| WO2011140550A2 (en) * | 2010-05-07 | 2011-11-10 | Camas Incorporated | Immunogen adherence and method of making and using same |
| CA3111516C (en) | 2011-03-03 | 2023-05-23 | Impel Neuropharma, Inc. | Nasal drug delivery device |
| AU2012253569B2 (en) | 2011-05-09 | 2018-02-15 | Impel Pharmaceuticals Inc. | Nozzles for nasal drug delivery |
| CN108853093A (zh) | 2011-12-21 | 2018-11-23 | 明治制果药业株式会社 | 局部给药型的吞咽障碍改善用药物 |
| FI3412277T3 (fi) * | 2012-01-25 | 2023-03-23 | Chiesi Farm Spa | Kortikosteroidia ja beeta-adrenergista ainetta käsittävä kuivajauheformulaatio annettavaksi inhalaatiolla |
| WO2013144916A1 (en) * | 2012-03-30 | 2013-10-03 | Nuformix Limited | Tranilast compositions and cocrystals |
| US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| CA2901015A1 (en) * | 2013-03-04 | 2014-09-12 | Besins Healthcare Luxembourg Sarl | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles |
| CA2909954C (en) | 2013-04-28 | 2021-03-23 | Impel Neuropharma, Inc. | Medical unit dose container |
| US10149823B2 (en) | 2013-04-30 | 2018-12-11 | Otitopic Inc. | Dry powder formulations and methods of use |
| WO2014199486A1 (ja) * | 2013-06-13 | 2014-12-18 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 嚥下障害改善用医薬品 |
| US9974768B2 (en) | 2013-06-13 | 2018-05-22 | Meiji Seika Pharma Co., Ltd. | Pharmaceutical for improving dysphagia |
| MX2016002705A (es) * | 2013-09-03 | 2016-09-06 | G2B Pharma Inc | Formulacion intranasal para el tratamiento por reanimacion cardiopulmonar (rcp), mantenimiento cardiaco vital (cls), de anafilaxia y/o reacciones anafilactoides. |
| ES2904570T3 (es) * | 2013-09-24 | 2022-04-05 | Satsuma Pharmaceuticals Inc | Formulación de DHE intranasal para el tratamiento del dolor de cabeza |
| CA2875384A1 (en) | 2013-12-20 | 2015-06-20 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
| EP3281625B1 (en) * | 2015-04-07 | 2020-02-26 | Nipro Corporation | Oral film preparation |
| MX2018002895A (es) | 2015-09-10 | 2018-07-06 | Impel Neuropharma Inc | Dispositivo de administracion nasal en linea. |
| US11844859B2 (en) | 2017-08-20 | 2023-12-19 | Nasus Pharma Ltd. | Dry powder compositions for intranasal delivery |
| WO2019038756A1 (en) | 2017-08-20 | 2019-02-28 | Solubest Ltd. | DRY POWDER COMPOSITIONS FOR INTRANASAL DELIVERY |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| CN115919780A (zh) | 2017-09-22 | 2023-04-07 | 维克图拉公司 | 含有硬脂酸镁的干粉组合物 |
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
| EP3713628A4 (en) | 2017-11-21 | 2021-08-18 | Impel Neuropharma Inc. | INTRA-NASAL DEVICE WITH DIVER TUBE |
| CN111372635B (zh) | 2017-11-21 | 2022-08-16 | 英倍尔制药公司 | 带有入口接口的鼻内装置 |
| CN111386119A (zh) | 2017-11-27 | 2020-07-07 | Aska制药株式会社 | 粉末鼻腔给药制剂 |
| AU2019205329B2 (en) | 2018-01-05 | 2023-04-20 | Impel Pharmaceuticals Inc. | Intranasal delivery of olanzapine by precision olfactory device |
| RU2020125871A (ru) | 2018-01-05 | 2022-02-07 | Импел Ньюрофарма, Инк. | Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область |
| WO2019182745A1 (en) | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Epinephrine spray formulations |
| WO2019199704A1 (en) | 2018-04-09 | 2019-10-17 | Katana Pharmaceuticals, Inc. | Oxytocin compositions and methods of use |
| CN112955134A (zh) | 2018-07-19 | 2021-06-11 | 英倍尔药业股份有限公司 | 用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送 |
| CN120284965A (zh) | 2018-12-11 | 2025-07-11 | 小蜜橘制药公司 | 用于治疗或预防头痛的组合物、装置和方法 |
| CN113473967B (zh) | 2019-01-03 | 2022-09-09 | 英倍尔制药公司 | 经鼻药物递送装置 |
| EP3970696A4 (en) * | 2019-05-16 | 2023-03-01 | Shin Nippon Biomedical Laboratories, Ltd. | POWDER PREPARATION FOR TRANSNASAL ADMINISTRATION AND MANUFACTURING METHOD THEREOF |
| WO2020236658A1 (en) | 2019-05-17 | 2020-11-26 | Impel Neuropharma, Inc. | Single-use nasal delivery device |
| CN115279371A (zh) * | 2020-01-14 | 2022-11-01 | 英倍尔制药公司 | 重复施用双氢麦角胺治疗频繁偏头痛 |
| US20210283074A1 (en) * | 2020-03-16 | 2021-09-16 | Nasus Pharma Ltd. | Polymeric Compositions for Intranasal Administration |
| CA3204459A1 (en) * | 2020-12-16 | 2022-06-23 | Liw Innovation Ab | A new powder composition |
| WO2025220834A1 (ko) * | 2024-04-16 | 2025-10-23 | 한미약품 주식회사 | 흡입제 조성물 |
Family Cites Families (128)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2224175B1 (enExample) * | 1973-04-04 | 1978-04-14 | Isf Spa | |
| IT1017153B (it) * | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
| AU508480B2 (en) * | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
| JPS5420126A (en) | 1977-07-12 | 1979-02-15 | Asahi Chem Ind Co Ltd | Pharmaceutical composition |
| JPS53127553A (en) | 1977-04-13 | 1978-11-07 | Asahi Chem Ind Co Ltd | Vehicle |
| JPS5462328A (en) | 1977-10-24 | 1979-05-19 | Asahi Chem Ind Co Ltd | Additive for cosmetics |
| US4226233A (en) * | 1978-10-10 | 1980-10-07 | Longevity Products, Inc. | Respirators |
| US4300545A (en) * | 1980-06-23 | 1981-11-17 | Schering Corporation | Method and nozzle for nasal vaccination of immature mammals |
| JPS5934267A (ja) | 1982-08-23 | 1984-02-24 | 帝人株式会社 | 粉状薬剤施薬装置 |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| DE3345722A1 (de) | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
| JPS60224616A (ja) | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
| JPS6242888A (ja) | 1985-08-21 | 1987-02-24 | カシオ計算機株式会社 | 太陽電池を備えたｉｃカ−ド |
| US5731303A (en) * | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
| JPS63267731A (ja) | 1987-04-23 | 1988-11-04 | Asahi Chem Ind Co Ltd | 錠剤組成物 |
| JPS6475800A (en) | 1987-09-16 | 1989-03-22 | Mitsui Constr | Concrete spraying device |
| KR890006252A (ko) * | 1987-10-15 | 1989-06-12 | 헤르비그 폰 모르체 | 분말형 폴리펩타이드의 비강내 투여용 조성물 및 투여방법 |
| JPH02196719A (ja) * | 1989-01-24 | 1990-08-03 | Green Cross Corp:The | 粉末状医薬組成物 |
| US4947097A (en) | 1989-06-12 | 1990-08-07 | The Grass Valley Group, Inc. | Automatic switching of motion control with tactile feedback |
| DK198591D0 (da) * | 1991-12-10 | 1991-12-10 | Novo Nordisk As | Apparat |
| US5320094A (en) * | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
| GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
| US5417984A (en) * | 1992-12-14 | 1995-05-23 | Biocontrol, Inc. | Low crystallinity cellulose excipients |
| EP0681491B1 (en) * | 1993-01-29 | 2000-12-13 | Aradigm Corporation | Intrapulmonary delivery of hormones |
| US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
| EP0689438B1 (en) * | 1993-03-26 | 2003-06-04 | Franciscus Wilhelmus Henricus Maria Merkus | Pharmaceutical compositions for intranasal administration of apomorphine |
| JPH07165613A (ja) | 1993-10-19 | 1995-06-27 | Dot:Kk | 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物 |
| SE9303574D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
| US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
| US5804209A (en) * | 1994-06-16 | 1998-09-08 | Pharmacia S.P.A. | Bioadhesive starches and process for their preparation |
| JPH0898888A (ja) | 1994-09-30 | 1996-04-16 | Teijin Ltd | 粉末状薬剤噴霧施薬装置 |
| JP3308419B2 (ja) | 1995-02-06 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
| JP3308425B2 (ja) | 1995-03-10 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
| JPH08243164A (ja) | 1995-03-13 | 1996-09-24 | Unisia Jecs Corp | 鼻腔用投薬器 |
| JP3320261B2 (ja) * | 1995-06-01 | 2002-09-03 | 株式会社ユニシアジェックス | 吸入式投薬器 |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| JP3317827B2 (ja) * | 1995-10-09 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
| CA2247191C (en) | 1996-02-27 | 2005-01-04 | Teijin Limited | Powdery composition for nasal administration |
| JP3197221B2 (ja) | 1996-02-27 | 2001-08-13 | 帝人株式会社 | 吸収性が改善された粉末状経鼻投与組成物 |
| JP3197223B2 (ja) | 1996-02-28 | 2001-08-13 | 帝人株式会社 | 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物 |
| JPH09253208A (ja) * | 1996-03-21 | 1997-09-30 | Unisia Jecs Corp | 鼻腔用投薬器 |
| JPH09276405A (ja) | 1996-04-15 | 1997-10-28 | Unisia Jecs Corp | 鼻腔用投薬器 |
| US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| JP3020141B2 (ja) * | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
| GB9700624D0 (en) | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| US6298846B1 (en) * | 1997-01-30 | 2001-10-09 | Unisia Jecs Corporation | Suction type medicator |
| DE69814428T2 (de) | 1997-09-29 | 2004-05-13 | Nektar Therapeutics, San Carlos | In verneblern verwendbare, stabilisierte zubereitungen |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| RU2184570C2 (ru) * | 1997-09-30 | 2002-07-10 | Дайити Фармасьютикал Ко., Лтд. | Препараты для орального введения |
| FR2771012B1 (fr) * | 1997-11-17 | 2000-03-10 | Sofab | Pulverisateur nasal |
| JPH11216357A (ja) | 1998-02-03 | 1999-08-10 | Tsutsumi Techno Planning Kk | 生理活性物質用の吸着担体 |
| JP3530004B2 (ja) * | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| GB9807232D0 (en) * | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
| JPH11322582A (ja) | 1998-05-06 | 1999-11-24 | Dot:Kk | 経鼻吸収用鼻粘膜付着・滞留型キャリヤ |
| GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| ES2242398T3 (es) * | 1998-06-05 | 2005-11-01 | Warner-Lambert Company Llc | Estabilizacion de composiciones que contienen inhibidores de la enzima de conversion de la angiotensina utilizando oxido de magnesio. |
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| CA2341732C (en) | 1998-08-26 | 2008-08-19 | Teijin Limited | Powder composition for nasal administration |
| ATE331532T1 (de) | 1998-08-26 | 2006-07-15 | Teijin Ltd | Pulverförmige pernasale mittel |
| US6264975B1 (en) | 1998-10-20 | 2001-07-24 | The University Of North Carolina At Chapel Hill | Methods of hydrating mucosal surfaces |
| GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| JP2000229859A (ja) | 1999-02-12 | 2000-08-22 | Teijin Ltd | 安定なブプレノルフィン経鼻製剤 |
| JP2000239187A (ja) | 1999-02-22 | 2000-09-05 | Dotto:Kk | 経鼻吸収用組成物 |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| JP3912469B2 (ja) | 1999-05-13 | 2007-05-09 | セイコーエプソン株式会社 | 偽造印刷物判定用インク |
| JP2001055323A (ja) | 1999-08-12 | 2001-02-27 | Teijin Ltd | 粉末状経鼻投与用組成物 |
| US6197328B1 (en) * | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
| AU7685200A (en) | 1999-10-12 | 2001-04-23 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
| DE10049392A1 (de) * | 1999-10-14 | 2001-04-19 | Becton Dickinson Co | Flüssigkeits-Ausgabevorrichtung |
| GB9925934D0 (en) | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
| ES2220724T3 (es) * | 2000-01-20 | 2004-12-16 | Basilea Pharmaceutica Ag | Composiciones de peptidos ciclicos administrables por via nasal. |
| ES2266201T3 (es) * | 2000-06-12 | 2007-03-01 | Teijin Limited | Dispositivo administrador de dosis multiples de medicina en polvo. |
| DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| EP1328260A2 (en) | 2000-10-18 | 2003-07-23 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
| JP2002161030A (ja) * | 2000-11-27 | 2002-06-04 | Unisia Jecs Corp | 異なる粒径をもった混合粉体の吸入方法 |
| US6595210B2 (en) * | 2000-11-27 | 2003-07-22 | Unisia Jecs Corporation | Inhalator for administering powder composition |
| JP2002255795A (ja) | 2001-02-26 | 2002-09-11 | Teijin Ltd | 経鼻投与用組成物 |
| WO2002094233A1 (en) | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of antiemetics through an inhalation route |
| KR20030027108A (ko) | 2001-07-05 | 2003-04-03 | 트렌스레셔널 리서치 가부시키가이샤 | 인슐린의 경비 투여용 조성물 |
| WO2003024396A2 (en) * | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Dry powder medicament formulations |
| DE60222160T2 (de) * | 2001-10-12 | 2008-06-12 | Elan Pharma International Ltd., Athlone | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung |
| JP3975327B2 (ja) | 2001-11-19 | 2007-09-12 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
| WO2003045357A1 (en) * | 2001-11-27 | 2003-06-05 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
| JP2003175103A (ja) | 2001-12-12 | 2003-06-24 | Teijin Ltd | 粉末薬剤多回投与器 |
| FR2834212B1 (fr) | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
| JP4212019B2 (ja) | 2002-01-09 | 2009-01-21 | Ｔｒａｎｓｌａｔｉｏｎａｌ Ｒｅｓｅａｒｃｈ 株式会社 | 薬物の経鼻投与用組成物 |
| CN1642524B (zh) | 2002-03-12 | 2011-05-18 | 微计量治疗公司 | 通过吸入部位特异性递送联合施用的药物 |
| AU2003209851A1 (en) * | 2002-03-20 | 2003-09-29 | The University Of Queensland | Method of treatment and/or prophylaxis |
| JP3950738B2 (ja) * | 2002-05-14 | 2007-08-01 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
| US7947742B2 (en) * | 2002-06-28 | 2011-05-24 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
| WO2004004692A1 (en) * | 2002-07-08 | 2004-01-15 | Ranbaxy Laboratories Limited | Processes for the preparation of oral dosage formulations of modafinil |
| GB0215904D0 (en) | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
| US6855913B2 (en) * | 2002-08-06 | 2005-02-15 | Hobart Brothers Company | Flux-cored wire formulation for welding |
| CN1176649C (zh) * | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| GB2395900A (en) * | 2002-12-04 | 2004-06-09 | Elan Drug Delivery Ltd | Therapeutic composition for respiratory delivery |
| GB0228826D0 (en) | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| US20040173211A1 (en) * | 2003-01-14 | 2004-09-09 | Boehringer Ingelheim International Gmbh | Powder inhaler |
| KR20050096950A (ko) * | 2003-01-31 | 2005-10-06 | 오렉쏘 에이비 | 신속-작용 약학 조성물 |
| US7638138B2 (en) * | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
| JP4136724B2 (ja) | 2003-03-05 | 2008-08-20 | 株式会社日立製作所 | 鼻腔用投薬器 |
| WO2004082506A1 (de) * | 2003-03-21 | 2004-09-30 | Alfred Schmid Ag Gossau | Mischkapsel |
| MXPA05010379A (es) * | 2003-03-27 | 2006-05-31 | Bioactis Ltd | Aparato para administrar una medicina en polvo en la cavidad intranasal. |
| US20070184109A1 (en) * | 2003-06-06 | 2007-08-09 | Floyd Alison G | Compositions comprising triptans and nsaids |
| EP1635762B1 (en) * | 2003-06-13 | 2021-03-03 | Civitas Therapeutics, Inc. | Low dose pharmaceutical powders for inhalation |
| US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
| MXPA06003830A (es) * | 2003-10-09 | 2006-07-03 | Bioactis Ltd | Aparato para abastecer medicina pulverizada para la cavidad nasal. |
| GB0328186D0 (en) | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
| US8545881B2 (en) * | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| ES2909080T3 (es) | 2004-04-23 | 2022-05-05 | Cydex Pharmaceuticals Inc | Formulación de DPI que contiene sulfoalquil éter ciclodextrina |
| US8673360B2 (en) * | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
| EP2277577B1 (en) * | 2004-10-06 | 2018-03-14 | Boehringer Ingelheim International Gmbh | Dispensing device for dispensing powder |
| CA2583101A1 (en) | 2004-10-15 | 2006-04-20 | Pfizer Products Inc. | Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| CA2617909C (en) * | 2005-08-05 | 2014-02-04 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| US8998881B2 (en) * | 2005-08-10 | 2015-04-07 | Alza Corporation | Method for delivering drugs to tissue under microjet propulsion |
| ATE398451T1 (de) * | 2005-08-29 | 2008-07-15 | Teva Pharma | Festes, teilchenförmiges tadalafil mit bimodaler teilchengrössenverteilung |
| CN101336105A (zh) * | 2006-01-31 | 2008-12-31 | 特瓦制药工业有限公司 | 奥卡西平药物制剂及其制备方法，其中奥卡西平具有宽且多峰的粒度分布 |
| TW200811104A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
| US7806117B2 (en) * | 2006-06-07 | 2010-10-05 | Shin Nippon Biomedical Laboratories, Ltd. | Peroral powder delivery device |
| CA2659245A1 (en) * | 2006-07-28 | 2008-01-31 | Novadel Pharma Inc. | Anti-migraine oral spray formulations and methods |
| US20080029084A1 (en) * | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Device for improved peptide delivery |
| BRPI0716884A2 (pt) | 2006-09-07 | 2013-10-15 | Parion Sciences Inc | Método de intensificação de hidratação mucosal e clearance mucosal através de tratamento com bloqueadores do canal de sódio e osmolitos |
| GB0625322D0 (en) * | 2006-12-19 | 2007-01-24 | Pharmakodex Ltd | Pharmaceutical compositions |
| JP5415769B2 (ja) * | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
| GB2448183A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| US8486043B2 (en) * | 2007-10-12 | 2013-07-16 | Map Pharmaceuticals, Inc. | Inhalation drug delivery |
| JP2011510964A (ja) * | 2008-02-01 | 2011-04-07 | ヴェクトゥラ リミテッド | トリプタン類の肺用製剤 |
| GB2472327B (en) * | 2009-07-31 | 2013-03-13 | Shin Nippon Biomedical Lab Ltd | Intranasal granisetron and nasal applicator |
-
2010
- 2010-05-14 US US12/780,433 patent/US9101539B2/en active Active
- 2010-05-14 WO PCT/JP2010/003285 patent/WO2010131486A1/en not_active Ceased
- 2010-05-14 JP JP2011548484A patent/JP2012526726A/ja active Pending
- 2010-05-14 EP EP10774745.3A patent/EP2429495A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526726A5 (enExample) | ||
| JP7042015B2 (ja) | 経口投与型コルチコステロイド組成物 | |
| JP6043281B2 (ja) | ４−アミノ−５−フルオロ−３−［６−（４−メチルピペラジン−１−イル）−１ｈ−ベンズイミダゾール−２−イル］−１ｈ−キノリン−２−オンラクテート一水和物を含む医薬組成物 | |
| EP1945186B1 (en) | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent | |
| ES2543108T3 (es) | Preparación sólida fácilmente administrable | |
| EP1787640A1 (en) | Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition | |
| AU2012250862B2 (en) | Rapid dissolve tablet compositions for vaginal administration | |
| JPWO2011118453A1 (ja) | 固形製剤 | |
| WO2010110322A1 (ja) | 固形製剤 | |
| WO2009034540A1 (en) | Pharmaceutical composition of sevelamer | |
| JPWO2010110320A1 (ja) | 固形製剤 | |
| JP2017523149A (ja) | エドキサバンの医薬組成物 | |
| JP2013531059A (ja) | マルチユニット錠剤組成物 | |
| JP2018509473A (ja) | ポリマーの水溶液 | |
| RU2709526C2 (ru) | Фармацевтические композиции, которые содержат лобеглитазон, для перорального введения | |
| CN106999436B (zh) | 含有分娩控制物质的口服崩解固体药物剂量单元 | |
| CN107106640B (zh) | 含有分娩控制物质的口服崩解固体药物剂量单元 | |
| JP6186139B2 (ja) | 口腔内速崩壊性錠剤 | |
| CN105596304B (zh) | 用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物 | |
| JP2016098230A5 (enExample) | ||
| JP2010059152A (ja) | モノステアリン酸グリセリンを含有するエナラプリルマレイン酸塩錠剤 | |
| HK1126394B (en) | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent | |
| JP2012012414A (ja) | 錠剤、およびその製造方法 | |
| AU2014233629A1 (en) | Orally administered corticosteroid compositions | |
| HK1235301A1 (en) | Pharmaceutical compositions comprising lobeglitazone for oral administration |